CV: Nicholas A Votolato RPh BCPP

Nicholas A Votolato, RPh BCPP
Clinical Assistant Professor
Department of Psychiatry
College of Medicine
The Ohio State University

Answers questions in the following forums:

Education:

1971-1974. The Ohio State University (Pharmacy)
1969-1971. Kent State University (Chemistry)

Licensure or Certification:

Board Certification (BCPP) 1996, 2003

Associations:

The International Society for CNS Clinical Trials and Methodology (ISCTM)
Clinical Psychopharmacy and Neurology Pharmacists (CPNP) (Founding Member)
American Society of Health System Pharmacists (ASHP)
Ohio Society of Health Systems Pharmacists (OSHP)
Central Ohio Society of Health Systems Pharmacists (COSHP)
President State Employed Pharmacists Association
Board Member Stark County Council on Drug Abuse

Affiliations:

1978 - present. Clinical Pharmacy Specialist/Neuropsychiatry
The Ohio State University Medical Center
1978 - present. Clinical Assistant Professor (Psychopharmacology)
The Ohio State University
Departments of Psychiatry & Pharmacy
Division of CNS Pharmacogenomics

Partial List of Publications:

Utility of THE INTENSIVE CARE DELIRIUM SCREENING CHECKLIST in a Medical Intensive Care Unit at a University Medical Center (in press)
Electrocardiographic Evaluation of Intramuscular Formulation of Ziprasidone in Journal of Clinical psychopharmacology Children and Adolescents (in press)
Mirtazapine Improves Tolerability of Venlafaxine in Hospitalized Patients with Major Depressive Disorder. Smith, D, Chan, Y, and Votolato N. (in press)
The Use of Intramuscular Benzodiazepines and Antipsychotic Agents in the Treatment of Agitation or Violence in the Emergency Department” Journal of Emergency Medicine Oct;31(3):317-24.
Fulminant Hepatic Failure Involving Duloxetine Hydrochloride. Clinical Gastroenterology and Hepatology A. James Hanje, Lindsay J Pell, Nicholas A Votolato et al Vol 4:(7) 2006.
Effect of Alpha-2 Adrenergic Agonists on Memory and Cognitive Flexibility. Cognitive and behavioral neurology Choi, Youngjee (1) Novak, John C. (2) Hillier, Ashleigh, Votolato, Nicholas A., (3) Beversdorf, David Q, 19(4) Dec 2006.
American Society of Health Systems Pharmacists PharmPrep Book 2006
Chapter: Major Depression. Votolato NA, Martin S
American Society of Health Systems Pharmacists PharmPrep Book 2006
Chapter: Bipolar Disorder. Votolato NA, Martin S
American Society of Health Systems Pharmacists PharmPrep Book 2006
Chapter: Anxiety Disorders. Smith S, Votolato NA
Worsening of Psychotic Symptoms in Schizophrenia with Addition of Lamotrigine: A Case Report Schizophrenia Res. 2005 Aug 4 Chan YC, Miller KM, Shaheen N, Votolato NA, Hankins MB.
Elevated Defibrillation Threshold with Venlafaxine Treatment: A Case Report Pharmacotherapy Pharmacotherapy 2004 vol 24(8) 1095-1098. Cynthia A. Carnes, Pharm.D., Ph.D.Kerry K. Pickworth, Pharm.D. Nicholas A. Votolato,. Subha V. Raman, MD
Evaluating the reconstitution of intramuscular ziprasidone (Geodon) into solution. Ann Emerg Med. 2004 Mar;43(3):419-20. Ewing JD, Rund DA, Votolato NA.
American Society of Health Systems Pharmacists PharmPrep Book 2003 Major Depression. Votolato NA
Management of Bipolar Disorder and Side Effects Caused by Medications Votolato NA OPA Journal/Website CE 2003.
Serotonergic antidepressants and urinary incontinence. Votolato NA, Stern SL, Caputo RM. International Urogynecology J Pelvic Floor Dysfunction 2001 11(6):386-8.
Depression in women:Special considerations in diagnosis and management. Burt VK, Votolato NA.Overview of Selected CNS Disorders 2001. CNS News 23-41.
Does Zinc moderate essential fatty acid and amphetamine treatment of attention-deficit/hyperactivity disorder. Arnold LE, Pinkham SM, Votolato NA, J Child Adolescent Psychopharamcology 2000 Summer 10(2):111-7.
The newer antidepressants. Stern SL, Votolato NA, Hatch JP, Bowden CL. Psychiatric Services 2000;51(8):1051-1052
Premenstral Dysphoric Disorder. Gorman DM, Votolato NA Ohio Society of Health-Systems Pharmacists Bulletin 2000, 20(4)4-7.
Management of Depression: A focus on newer agents. Current Concepts in Pharmacy Practice: Neurology Series. Votolato NA, Davies KL, McCauley JW. 2000.
Management of Epilepsy. Current Concepts in Pharmacy Practice: Neurology Series. McCauley JW, Peebles C, Votolato NA 2000.
Management of Migraines. Current Concepts in Pharmacy Practice: Neurology Series. Peebles C, McCauley JW, Votolato NA 2000
Management of Chronic Pain. Current Concepts in Pharmacy Practice: Neurology Series. Peebles C, McCauley JW, Votolato 2000
Management of Parkinson’s Disease. Current Concepts in Pharmacy Practice: Neurology Series. Schindler L, Votolato NA, Davies KL, McCauley JW 2000
Management of Dementia. Current Concepts in Pharmacy Practice: Neurology Series. Davies KL, Votolato NA, Schindler L, McCauley JW 2000.
Research units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. McDougle CJ, Scahill L, McCracken JT, Aman MG, Tierney E, Arnold LE, Freeman BJ, Martin A, McGough JJ, Cronnin P, Posey DJ, Riddle MA, Ritz L, Swiezy NB, Vitiello B, Vlkmar FR, Votolato NA, Walson P. Child and Adolescent Psychiatry Clinics of North America, 2000 Jan;9(1), 201-224
Boutros NN, Guerra BM, Votolato NA, Smith S. Carbamazepine -induced hyponatremia resolved with doxycycline. J Clin Psychiatry Aug56(8):377-8, 1996.
Votolato NA Trends in Treating Depression: Pharmacokinetics of Antidepressants and Potential Drug Interactions. U.S Pharmacist supp 8 : 1-7, 1995.
Votolato NA, Smith S. The selective serotonin inhibitors (SSRI?s) Bulletin, The Ohio State University Hospitals. Fall 1993.
McCoy L, Votolato NA Schwartzkopf SB, Nasrallah HA. Clinical correlates of valproate augementation in refractory bipolar disorders. Annals of Clinical Psychiatry 5(1):29-33, 1993.
Votolato NA Critical issues in generic substitution J. Clinical Psychiatry Monograph 7:1 1-10, 1993.
Arnold LE Votolato NA Kleykamp D Baker GB Bornstein RA. Does hair zinc predict amphetamine improvement of ADD/hyperactivity. Int J of Neuroscience 50(1-2):103-7, 1990.
Dilsaver SC Votolato NA Phenylpropanolamine reply American Family Physician 41(2) 438-451, 1990.
Dilsaver SC Votolato NA Alessi NE. Complications of Phenylproanolamine. American Family Physician 39(4):201-6 1989.
Arnold LE Kleykamp D Votolato NA Taylor WA Kontras SB Tobin K. Gamma- linolenic acid for attention-deficit hyperactivity disorder: placebo-controlled comparison to D-amphetamine. Biological Psychiatry 25(2):222-8 1989.
Dilsaver SC Votolato NA Coffman JA Model curriculum Neurology 38(9):1505-6 1988.
Votolato NA Batcha KJ Olson SC Diazepam Testing in alprazolam withdrawal. Drug Intelligence and Clinical Pharmacy 21(9) 654-5, 1987.
Nemzer ED Arnold LE Votolato NA McConnell H. Amino acid supplementation as therapy for attention deficit disorder. Journal of the Academy of Child Psychiatry 25(4):509-13 1986.
Schmidt H Votolato NA Yohimbine in the treatment of obstructive sleep apnea Sleep Research 15:164, 1986 .
Levy AB Bucher P Votolato NA Myoclonus, hyperreflexia and diaphoresis in patients on phenelzine-tryptophan combination treatment. Can J Psychiatry 30(6) 434-6, 1985.
Votolato NA Effectively using polycyclic antidepressants. Bulletin The Ohio State University Hospitals Fall 1985
Schmidt H Votolato NA Yohimbine in thre treatment of impotence. Sleep Research 13:125, 1984.

Research:

RESEARCH INTERESTS AND INVOLVEMENTS (Career)
Pharmacokinetics of psychotropic agents
Cytochrome Isoenzyme Systems
Cardiovascular effects of psychotropic agents
Pharmacotherapy in Schizophrenia
Pharmacotherapy in Bipolar Disorder
Pharmacotherapy in Depression
Pharmacotherapy in Comorbid Medical States
Pharmacotherapy in Geriatrics
Pharmacotherapy in Epilepsy/Mood
Pharmacotherapy in Anxiety Disorders
Pharmacotherapy in Withdrawal States
Pharmacotherapy of Attention
Deficient and Hyperactivity Disorder
Pharmacotherapy in Winter Depression
Pharmacotherapy of Aggressive Behavior
Pharmacotherapy of Bulimia
Identification and Treatment of Movement Disorders
Sleep Disorders
Academic detailing (PORT)
Nicotine Cessation
Psychopharmacologic Treatment of Poststoke
Neuropsychopharmacology
RESEARCH PROJECTS/DRUGS INVOLVED WITH IN CAREER
Combination Psychotropics and Weight Gain in Children
Continuation Therapy of Antidepressants
Olanzapine Zydis (Pharmacokinetics)
Risperidone -M (Pharmacokinetics)
Ziprasidone Parenteral Use and Stability)
Aripriprazole in Children
Pharmacogenomics in Psychosis
Pharmacogenomics in Bipolar Disorder
Venlafaxine and Mirtazepine in Hospitalized Depression
Risperidone in Acute Mania
Valproate in Acute Mania
Valproate in Maintenance Bipolar Disorder
Academic detailing study: Pharmacologic Treatment Recommendations
Schizophrenia Patient Outcomes Research Team (PORT)
Sertindole in Schizophrenia
Quetiapine in Schizophrenia
Ziprasidone in schizophrenia
Olanzapine vs Risperidone in schizophrenia
Research units of Pediatric Psychopharmacology (RUPP) studies
Fluvoxamine in Major Depression
Citalopram in Major Depression
Selective Serotonin Reuptake Inhibitor Surveylance Drug Interaction Project
Desipramine in Bulimia
Imipramine in agoraphobia
Yohimbine in impotence
Pentoxiphyline in impotence
L-tryptophan in sleep apnea

Grants:

A Phase II Randomized XBD 173 in Generalized Anxiety Disorder
A Phase III, Randomized, Placebo-Controlled, Double-Blind Study Evaluating the Safety and Efficacy of Sublingual Asenapine vs Olanzapine and Placebo in inpatients with an Acute Manic Episode.
A Phase III, Randomized, Double-Blind, Flexible-dose, 6 Month Trial Comparing the Safety and Efficacy of Asenapine with Olanzapine in Stable Patients with Predominant, Persistent Negative Symptoms of Schizophrenia.
Other Studies in Progress
Cognitive Differences between Antidepressants in HIV Patients Using the Digit Symbol Substitution Test
Effects of Psychotropic Agents in Patients Receiving ECT
Dyslipidemia and Response Patterns of Patients receiving ECT
Tolerability of Aripiprazole in the Treatment of Bipolar Disorder in Children and Adolescents
Transaminase Elevations of Combination of Divalproex and Olanzapine in Children and Adolescents
Pharmacogenomics in first episode schizophrenia
A double blind comparison of bupropion XL and placebo in the prevention of seasonal depressive episodes in patients with a history seasonal affective disorder
Comparison of pharmacokinetics of Olanzapine-ZydisR and Risperidone-MR in healthy human subjects
Solubility of Risperidone-MR and Olanzapine-Zydis in different administration solutions
Cost analysis of Risperidone-M versus Risperidone liquid in hospitalized patients.
Tolerability of Aripiprazole in hospitalized children and adolescents
Assessment of long-term continuation therapy of antidepressants in a VA population
Assessment of weight gain in long-term use of antidepressants in a VA population
Use of a visual analogue scale to assess the effectiveness of intramuscular ziprasidone in a university emergency department
The changes of Cytochrome P-450 2D6 in the first trimester of pregnant bipolar manic patients through plasma levels of perphenazine
Electrophysiological differences of antidepressants on pacemakers in patients with cardiomyopathy
Acute weight changes in hospitalized children and adolescents on combination therapy of mood stabilizers
Tolerability, Safety, and efficacy or ziprasidone IM in child and adolescents
Effect of lamotrigine on patients receiving ECT
Effect of venlafaxine in patients receiving ECT

Awards:

Distinguished Visiting Professor, University of Texas, Department of Psychiatry 2004
Outstanding Faculty Department of Psychiatry 1997, 2003
Outstanding Faculty College of Pharmacy 1993

Answers questions in the following forums:

Education:

Licensure or Certification:

Associations:

Affiliations:

Partial List of Publications:

Research:

Grants:

Awards:

Web Links: